Hydroxyurea
Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxyurea activates apoptosis and autophagy. Hydroxyurea is used to treat HIV infection.
| Trivial name | NCI-C04831, Hydroxycarbamide,NSC-32065 |
| Catalog Number | S1896 |
| Molecular Formula | C23H31N3O4S2 |
| CAS# | 127-07-1 |
| Inchi | InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1 |
| Inchi Key | XFILPEOLDIKJHX-QYZOEREBSA-N |
| SMILES | CC(C)CC(C(CSC1=CC=CS1)C(=O)NO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/Hydroxyurea(Cytodrox).html |
| Additional Information | https://file.selleck.cn/downloads/struct/Hydroxyurea-Cytodrox-chemical-structure-S1896.gif |